Cognitive Testing for Huntington's Disease Study
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study tests new ways to measure thinking and memory skills in people with Huntington's disease. It aims to find better tools for tracking the disease and could help you understand your cognitive changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 65 years old.
- You must have a genetic test showing 40 or more CAG repeats for Huntington's disease.
- A doctor must have confirmed you have Huntington's disease (with 100% confidence).
- Your vision and hearing must be good enough to complete the study tests.
- If you take medications, they must be at the same dose for at least 30 days before starting the study.
- You cannot have any other serious brain disorders or major medical conditions (like cancer, heart failure, or seizures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special brain imaging and memory/thinking tests to find early “markers” that can predict how Huntington’s disease will progress over time. You may qualify as someone with early-stage Huntington’s or as a healthy control, if you meet specific safety and scoring requirements.
This trial uses a hinting task to study how people with Huntington's disease understand indirect requests. It may help researchers learn more about social thinking in this condition.
This study looks at how people with Huntington's disease (HD) remember past events and imagine future ones, and how their eye movements relate to these abilities. It may help us better understand thinking and memory changes in HD.
This study looks at specific “biomarkers” (measurable signs) found in cerebrospinal fluid, to better understand Huntington’s disease. The results may help researchers track the disease and improve future tests or treatments.
This study uses repeat brain scans (including PET and MRI) to track changes in the brain caused by Huntington’s disease over time. It may help researchers understand disease progress and test how well the scans reflect early vs later disease.
This study uses smartphone and wearable sensors to track movement and thinking in people with Huntington's disease. It aims to find better ways to measure how the disease progresses in clinical trials.
Hear when a new Huntington Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.